Condition
Double-Expressor Lymphoma clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Double-Expressor Lymphoma clinical trials that are recruiting, at sites in 2 countries (most in United States (1), China (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
CX-5461 (Pidnarulex) for aggressive B‑cell lymphomas with MYC gene changes
This trial tests whether the IV drug CX-5461 (Pidnarulex) is safe and can shrink or control aggressive B‑cell lymphomas that have MYC gene changes in adults who have already had other treatments.
-
Treatment for elderly patients with newly diagnosed double-expressor lymphoma
This study is testing a new combination of treatments for older patients with a specific type of lymphoma to see if it helps them feel better and stay in remission.
Related topics
Quick answers
How many Double-Expressor Lymphoma clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.